Publication:
Pyridoxine and Pyridostigmine Treatment in Vincristine-Induced Neuropathy

Simple item page
dc.authorscopusid6603156640
dc.authorscopusid9841285300
dc.authorscopusid19639690200
dc.authorscopusid14619141700
dc.authorscopusid19640001600
dc.authorscopusid7007038407
dc.contributor.authorÖzyürek, H.
dc.contributor.authorTürker, H.
dc.contributor.authorAkbalik, M.
dc.contributor.authorBayrak, A.O.
dc.contributor.authorInce, H.
dc.contributor.authorDuru, F.
dc.date.accessioned2020-06-21T15:24:33Z
dc.date.available2020-06-21T15:24:33Z
dc.date.issued2007
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Özyürek] Hamit, Department of Pediatrics, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Türker] Hande Y., Department of Neurology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Akbalik] Mehtap, Department of Pediatrics, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Bayrak] Ayşe Oytun, Department of Neurology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Ince] Hülya, Department of Pediatrics, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Duru] Feride, Tip Fakultesi, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractVincristine is a commonly used antineoplastic drug and frequently causes neurotoxicity. Here the authors report a 4-year-old boy with acute lymphoblastic leukemia in whom vincristine-induced peripheral and cranial neuropathy developed during remission induction therapy. The patient seemed to benefit from pyridoxine and pyridostigmine therapy greatly and this therapy is recommended in patients with severe vincristine-induced neuropathy. Copyright © Informa Healthcare USA, Inc.en_US
dc.identifier.doi10.1080/08880010701451327
dc.identifier.endpage452en_US
dc.identifier.issn0888-0018
dc.identifier.issn1521-0669
dc.identifier.issue6en_US
dc.identifier.pmid17710662
dc.identifier.scopus2-s2.0-34548139755
dc.identifier.scopusqualityQ3
dc.identifier.startpage447en_US
dc.identifier.urihttps://doi.org/10.1080/08880010701451327
dc.identifier.volume24en_US
dc.identifier.wosWOS:000251931700016
dc.identifier.wosqualityQ3
dc.language.isoenen_US
dc.publisherTaylor & Francis Incen_US
dc.relation.ispartofPediatric Hematology and Oncologyen_US
dc.relation.journalPediatric Hematology and Oncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNeurotoxicityen_US
dc.subjectPyridostigmineen_US
dc.subjectPyridoxineen_US
dc.subjectVincristineen_US
dc.titlePyridoxine and Pyridostigmine Treatment in Vincristine-Induced Neuropathyen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu